The Limited Times

Now you can see non-English news...

FDA Experts: The Benefits of an 11-5 Year Old Vaccine Against Corona Outweigh the Risks - Walla! news

2021-10-23T11:05:31.782Z


U.S. Food and Drug Administration experts said the benefits of Pfizer vaccines for this age group outweigh the risk of side effects. Pfizer announced that the vaccine has shown 90.7% efficacy in disease prevention among 11-5 year olds. The report was released ahead of next week's vaccine approval hearing


  • news

  • Vaccine for corona

FDA Experts: The benefits of an 11-5 year old vaccine against corona outweigh the risks

U.S. Food and Drug Administration experts said the benefits of Pfizer vaccines for this age group outweigh the risk of side effects.

Pfizer announced that the vaccine has shown 90.7% efficacy in disease prevention among 11-5 year olds.

The report was released ahead of next week's vaccine approval hearing

Tags

  • Vaccine for corona

  • Corona virus

  • FDA

  • Pfizer

News agencies

Saturday, October 23, 2021, 13:55

  • Share on Facebook

  • Share on WhatsApp

  • Share on general

  • Share on general

  • Share on Twitter

  • Share on Email

0 comments

  • Aryeh Lev The mythological librarian of Kiryat Shmona went ...

  • The heads of the Bedouin sector in the Negev: "They are inciting against us, we need ...

  • Demonstration in Umm al-Fahm, October 22, 2021

  • Meeting of Foreign Ministers of Israel, the United States and the United Arab Emirates ...

  • Protection in the north: Three residents of Avtin were accused of arson ...

  • Finance Minister Avigdor Lieberman in an interview with Tal ...

  • President of China: "We will peacefully reunite with ...

  • A 20-year-old man was arrested on suspicion of murdering his mother at her home in Beit Shemesh ...

  • Arrest of "Mossad agents" in Turkey, from TV ...

  • Documentation of the activities of the multidimensional unit during Operation ...

  • Putin: "There are problematic issues to discuss";

    Bennett: "We'll talk ...

  • Chest experiment on Tinder

In the video: Research on the corona vaccine in 18-12 year olds: 90% effectiveness in infection and 93% in preventing symptoms (Photo: Clalit Health Services)

Experts from the US Food and Drug Administration (FDA) said last night (Saturday) that the benefits of administering vaccines against Corona made by Pfizer to 11-5 year olds outweigh the risk of side effects of the vaccine.

The FDA report has been released ahead of the discussion on vaccine approval for this age group, which will be held this coming Tuesday.



A few hours before the FDA announcement, Pfizer announced that a study conducted among this age group found that the vaccine showed 90.7% efficacy in disease prevention.

If the Pfizer vaccine is approved for children aged 11-5, they will receive two vaccines at a dose three times lower than that given to vaccinators over the age of 12. If approval is given at the hearing by regulators, US authorities may begin vaccinating this age group early. November.

More on Walla!

Pfizer: The vaccine for 11-5 year olds is 90.7% effective against corona

To the full article

More on Walla!

  • In the coming weeks: Pfizer will make a formal application to the FDA to vaccinate 11-5 year olds against Corona

  • Huge study on corona vaccine in 18-12 year olds: 90% efficacy in infection and 93% in symptom prevention

  • Due to the growing demand for effective treatment of pain, without side effects: B-Cure laser on sale

(Photo: Reuters)

The study was conducted by Pfizer in 2,268 children, some of whom received two doses of vaccine at a dose of 10 micrograms, a third of the dose received by adults and adolescents, and the rest received placebo doses.

Sixteen children who participated in the study were infected with corona, compared with only three who became infected after being vaccinated with Pfizer's vaccine.



Pfizer and Modernera vaccines have sometimes been linked to young men with myocarditis.

However, according to FDA experts, assuming the number of cases of myocarditis among 11-5 year olds is similar to the number of cases among 15-12 year olds who are already vaccinated against the virus, then it appears that the number of corona-related hospitalizations will be higher than the number of developmental hospitalizations Of myocarditis due to the vaccine.

Thus, according to experts, arises in most possible scenarios.



Last month senior medical officials in the United States said regulators are expected to make a decision on vaccine efficacy about three weeks from the time of application.

In the United States, coronary heart disease has soared in recent months, and in children under 12 in particular, since the more contagious delta strain has spread.

However, there is no indication that the delta strain is more dangerous to children than the original corona virus.

  • Share on Facebook

  • Share on WhatsApp

  • Share on general

  • Share on general

  • Share on Twitter

  • Share on Email

0 comments

Source: walla

All news articles on 2021-10-23

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.